Found: 216
Select item for more details and to access through your institution.
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 2, p. 186, doi. 10.1164/rccm.202303-0489OC
- By:
- Publication type:
- Article
Vessel and Airway Characteristics in One-Year Computed Tomography–defined Rapid Emphysema Progression: SPIROMICS.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 7, p. 1022, doi. 10.1513/AnnalsATS.202304-383OC
- By:
- Publication type:
- Article
Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 12, p. 1431, doi. 10.1164/rccm.202212-2330OC
- By:
- Publication type:
- Article
Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 6, p. 2151, doi. 10.1007/s12325-024-02855-4
- By:
- Publication type:
- Article
The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007–2012.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02841-y
- By:
- Publication type:
- Article
Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case Finding.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 8, p. 928, doi. 10.1164/rccm.202311-2120PP
- By:
- Publication type:
- Article
Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 3, p. 421, doi. 10.1513/AnnalsATS.202209-751OC
- By:
- Publication type:
- Article
Local heterogeneity of normal lung parenchyma and small airways disease are associated with COPD severity and progression.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02729-x
- By:
- Publication type:
- Article
Impact of the COVID-19 Pandemic on Outcomes of CAPTURE: A Primary Care Chronic Obstructive Pulmonary Disease Screening Clinical Trial.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Indoor Pollution and Lung Function Decline in Current and Former Smokers: SPIROMICS AIR.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 10, p. 1042, doi. 10.1164/rccm.202302-0207OC
- By:
- Publication type:
- Article
Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers.
- Published in:
- Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-023-02576-2
- By:
- Publication type:
- Article
Returning incidentally discovered Hepatitis C RNA-seq results to COPDGene study participants.
- Published in:
- NPJ Genomic Medicine, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41525-023-00379-4
- By:
- Publication type:
- Article
Repeatability of pulmonary quantitative CT measurements in a multi-center study: SPIROMICS.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 6, p. E1
- By:
- Publication type:
- Article
Repeatability of Pulmonary Quantitative Computed Tomography Measurements in Chronic Obstructive Pulmonary Disease.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 6, p. 657, doi. 10.1164/rccm.202209-1698PP
- By:
- Publication type:
- Article
From Conundrum to Cures, Pioneering Breakthroughs in Chronic Obstructive Pulmonary Disease Research: Introduction to an AJRCCM Special Issue.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 4, p. 339, doi. 10.1164/rccm.202307-1194ED
- By:
- Publication type:
- Article
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 5, p. 442, doi. 10.1001/jama.2023.11676
- By:
- Publication type:
- Article
Gold 2023: Highlights for primary care.
- Published in:
- NPJ Primary Care Respiratory Medicine, 2023, v. 33, n. 1, p. 1, doi. 10.1038/s41533-023-00349-4
- By:
- Publication type:
- Article
Understanding Early COPD.
- Published in:
- Respiratory Care, 2023, v. 68, n. 7, p. 881, doi. 10.4187/respcare.10612
- By:
- Publication type:
- Article
Genetic regulators of sputum mucin concentration and their associations with COPD phenotypes.
- Published in:
- PLoS Genetics, 2023, v. 19, n. 6, p. 1, doi. 10.1371/journal.pgen.1010445
- By:
- Publication type:
- Article
Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 21, p. 1832, doi. 10.1001/jama.2023.2065
- By:
- Publication type:
- Article
Residual Volume versus FRC Computed Tomography Assessment of Functional Small Airway Disease in Smokers with and without Chronic Obstructive Pulmonary Disease.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV1 decline: results from COPDGene and SPIROMICS.
- Published in:
- Frontiers in Physiology, 2023, p. 1, doi. 10.3389/fphys.2023.1144192
- By:
- Publication type:
- Article
A blood and bronchoalveolar lavage protein signature of rapid FEV<sub>1</sub> decline in smoking-associated COPD.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-32216-0
- By:
- Publication type:
- Article
Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV<sub>1</sub> decline: results from COPDGene and SPIROMICS.
- Published in:
- Frontiers in Physiology, 2023, p. 1, doi. 10.3389/fphys.2023.1144192
- By:
- Publication type:
- Article
A Response to: Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis".
- Published in:
- 2023
- By:
- Publication type:
- Letter
AJRCCM: Strength in Breadth.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 9, p. 1111, doi. 10.1164/rccm.202303-0543ED
- By:
- Publication type:
- Article
Global initiative for chronic obstructive lung disease 2023 report: gold executive summary.
- Published in:
- Journal of the Pan African Thoracic Society, 2023, v. 4, n. 2, p. 58, doi. 10.2529/JPATS_GES_2023
- By:
- Publication type:
- Article
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 7, p. 819, doi. 10.1164/rccm.202301-0106PP
- By:
- Publication type:
- Article
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
- Published in:
- Respirology, 2023, v. 28, n. 4, p. 316, doi. 10.1111/resp.14486
- By:
- Publication type:
- Article
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 6, p. 490, doi. 10.1001/jama.2023.0128
- By:
- Publication type:
- Article
Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease.
- Published in:
- Annals of the American Thoracic Society, 2023, v. 20, n. 1, p. 38, doi. 10.1513/AnnalsATS.202203-226OC
- By:
- Publication type:
- Article
Updated Definition of Chronic Obstructive Pulmonary Disease in the Global Initiative for Chronic Obstructive Lung Disease 2023 Executive Report: Expert Perspectives.
- Published in:
- touchREVIEWS in Respiratory & Pulmonary Diseases, 2023, v. 8, n. 1, p. 9, doi. 10.17925/USRPD.2023.8.1.9
- By:
- Publication type:
- Article
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 206, n. 11, p. 1317, doi. 10.1164/rccm.202204-0671PP
- By:
- Publication type:
- Article
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial.
- Published in:
- Respirology, 2022, v. 27, n. 12, p. 1034, doi. 10.1111/resp.14339
- By:
- Publication type:
- Article
Race and Sex Differences in Mortality in Individuals with Chronic Obstructive Pulmonary Disease.
- Published in:
- Annals of the American Thoracic Society, 2022, v. 19, n. 10, p. 1661, doi. 10.1513/AnnalsATS.202112-1346OC
- By:
- Publication type:
- Article
Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Severity of Functional Small Airway Disease in Military Personnel with Constrictive Bronchiolitis as Measured by Quantitative Computed Tomography.
- Published in:
- 2022
- By:
- Publication type:
- letter
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.
- Published in:
- Respiratory Research, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12931-022-02123-5
- By:
- Publication type:
- Article
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement: Executive Summary.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 206, n. 4, p. 379, doi. 10.1164/rccm.202206-1041ST
- By:
- Publication type:
- Article
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 1633, doi. 10.2147/COPD.S342244
- By:
- Publication type:
- Article
Reconsidering the Utility of Race-Specific Lung Function Prediction Equations.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Quantitative CT Correlates with Local Inflammation in Lung of Patients with Subtypes of Chronic Lung Allograft Dysfunction.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 4, p. 699, doi. 10.3390/cells11040699
- By:
- Publication type:
- Article
CT-Based Commercial Software Applications: Improving Patient Care Through Accurate COPD Subtyping.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 919, doi. 10.2147/COPD.S334592
- By:
- Publication type:
- Article
Variation in Demographic and Clinical Characteristics of Patients with COPD Receiving Care in US Primary Care: Data from the Advancing the Patient EXperience (APEX) in COPD Registry.
- Published in:
- Pragmatic & Observational Research, 2022, v. 13, p. 17, doi. 10.2147/POR.S342736
- By:
- Publication type:
- Article